Exploiting Plasmid-Mediated Resistance: Discovery of Small-Molecule Inhibitors for the Artificial Activation of the Kid-Kis Toxin-Antitoxin System in Plasmid R1
ISEF · 2022 Microbiology Second Award
Overview
Antibiotic resistance is one of the leading challenges to public health today, and a primary contributor to the rapid rise of resistance is plasmids, which facilitate the spread of multi-drug resistance genes within bacterial populations through horizontal gene transfer. Therefore, plasmids are critical targets to prevent the rapid spread of antibiotic resistance. In particular, low-copy number plasmids often contain toxin-antitoxin systems that act lethally when activated, so due to the role of toxin-antitoxin systems in facilitating internal cell death, the disruption of the protein-protein interaction between the toxin and the antitoxin may be a promising novel target for antibiotic development. Key interacting regions of the Kid-Kis toxin-antitoxin interaction were identified as binding sites for the de-novo design of small-molecule inhibitors using the webserver LEA3D. To predict the activity of novel inhibitors, a QSAR classification model was constructed with OCHEM using published experimental data on a related system. The most promising inhibitors with drug-like properties were molecules targeting the Glu66 to Arg72 region of the Kis antitoxin, as four out of five inhibitors were classified as active compounds. Calculations for Gibbs free energy (p=0.000000252) and pKd (p=0.000459) showed statistically significant binding affinity compared to control molecules with no known affinity for the target, representing a significant binding specificity towards the target interaction region. In the fight against antibiotic resistance, the design of small-molecule inhibitors targeting toxin-antitoxin systems may be an important discovery for the selective targeting of plasmid-mediated resistance through the application of internal mechanisms toward antibiotic development.
Awards (2)
- Second Award of $2,000 $2,000
- University of Arizona: Renewal Tuition Scholarship
Competition history
- ISEF 2022
Resources
Related projects
ISEF · 2022
Novel Inhibitors for Conserved Regions of RecA To Slow Bacterial Antibiotic Resistance
ISEF · 2016
Novel TolC Inhibitors: Computer-Aided Drug Discovery for MDR-Conferring Efflux Pumps
ISEF · 2025
Computational Design of Novel Small-Molecule Activators Targeting the AtlA Autolysin in Multi Drug-Resistant Staphylococcus aureus to Combat Antibiotic Resistance Through Internal Cell Death Mechanisms
ISEF · 2019
Computational Screening of Small Molecules for Antibacterial Agents that Target T-Box Riboswitches
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair